These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21075544)

  • 1. Necroptosis: a novel therapeutic target for glioblastoma.
    Jiang YG; Peng Y; Koussougbo KS
    Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel treatment for glioblastoma: integrin inhibition.
    Chamberlain MC; Cloughsey T; Reardon DA; Wen PY
    Expert Rev Neurother; 2012 Apr; 12(4):421-35. PubMed ID: 22449214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells.
    Westhoff MA; Zhou S; Bachem MG; Debatin KM; Fulda S
    Oncogene; 2008 Sep; 27(39):5169-81. PubMed ID: 18469856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
    Kesari S
    Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
    Maleniak TC; Darling JL; Lowenstein PR; Castro MG
    Cancer Gene Ther; 2001 Aug; 8(8):589-98. PubMed ID: 11571537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
    Jagannathan J; Prevedello DM; Dumont AS; Laws ER
    Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.
    Fukushima T; Kataoka H
    Anticancer Res; 2007; 27(6A):3685-92. PubMed ID: 17970029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).
    Yin D; Zhou H; Kumagai T; Liu G; Ong JM; Black KL; Koeffler HP
    Oncogene; 2005 Jan; 24(3):344-54. PubMed ID: 15531918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3.
    Ray SK; Patel SJ; Welsh CT; Wilford GG; Hogan EL; Banik NL
    J Neurosci Res; 2002 Jul; 69(2):197-206. PubMed ID: 12111801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapies in glioblastoma multiforme.
    McNamara MG; Mason WP
    Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways.
    Liu J; Albrecht AM; Ni X; Yang J; Li M
    Curr Mol Med; 2013 Mar; 13(3):352-7. PubMed ID: 23331007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
    Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
    Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
    Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
    Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells.
    Huang TY; Tsai TH; Hsu CW; Hsu YC
    J Agric Food Chem; 2010 Oct; 58(19):10639-45. PubMed ID: 20822178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.